Market Moves
Cleveland Startup Sells $350 Brain Stimulation Headset Without FDA Clearance While Clinical Trials Continue
U: The Mind Company began taking orders for a consumer neuromodulation device on March 18, marketing bold clinical claims that have not appeared in peer-reviewed literature. An FDA submission is planned for 2027.